10/1/2020 6:04:12 AM
AbbVie: Public Coverage Of SKYRIZI For Treatment Of Plaque Psoriasis Is Now Available Across Addl Jurisdictions
9/28/2020 8:01:36 AM
AbbVie Says FDA Granted Orphan Drug And Fast Track Designations For Elezanumab
9/14/2020 8:08:59 AM
Allergan Aesthetics And Skinbetter Science Announce The Launch Of New Long-term, Educational Initiative – DREAM
9/11/2020 9:44:45 AM
AbbVie (ABBV) Declares Quarterly Dividend of $ 1.18, Record Date 10/15/2020
9/11/2020 9:42:14 AM
AbbVie Declares Quarterly Cash Dividend Of $1.18, Payable Nov. 16, Record Oct. 15
9/4/2020 7:02:51 AM
AbbVie And I-Mab Sign Global Collaboration Agreement For Development Of Lemzoparlimab
8/25/2020 8:48:27 AM
AbbVie Submits Application For New Indication To FDA For RINVOQ
8/25/2020 8:04:40 AM
AbbVie And Harvard University Announce $30 Mln Collaborative Research Alliance
8/3/2020 7:37:07 AM
AbbVi, Amgen And Takeda Pharma Enroll First Patients In I-SPY COVID Trial
7/31/2020 7:44:39 AM
AbbVie Q2 GAAP Loss Per Share $0.46; Adj EPS $2.34